Newsfeeds - Spark Newswire

1 minute read

Biote Q3 Sales $41.97M Beat $41.86M Estimate

November 8, 5:27 PM

Biote (NASDAQ:BTMD) reported quarterly sales of $41.97 million which beat the analyst consensus estimate of $41.86 million by 0.26 percent. This is a 17.89 percent increase over sales of $35.60 million the same period

BTMD

21 minute read

Earnings

Earnings Scheduled For November 8, 2022

By Benzinga Insights

November 8, 5:32 AM

Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.

ABCL

6 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For September 27, 2022

By Benzinga Insights

September 27, 10:05 AM

Upgrades

ARCO

1 minute read

Truist Securities Initiates Coverage On Biote with Buy Rating, Announces Price Target of $10

By Benzinga Newsdesk

September 27, 7:17 AM

Truist Securities analyst Gregory Fraser initiates coverage on Biote (NASDAQ:BTMD) with a Buy rating and announces Price Target of $10.

BTMD

2 minute read

News

Biote Announces Strategic Partnership With IMAC Holdings Will Add Certain Biote Services To Its Network Of Outpatient Clinics That Deliver Orthopedic, Regenerative, And Advanced, Non-Surgical Medical Procedures; No Terms Disclosed

By Benzinga Newsdesk

September 7, 8:45 AM

Biote Method to be available in IMAC outpatient medical clinics biote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a high growth, differentiated medical practice-building business within

BACK

1 minute read

Movers

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

September 2, 8:07 AM

ADMA

3 minute read

Why Pagerduty Is Trading Higher By 9%; Here Are 28 Stocks Moving Premarket

By Lisa Levin

September 2, 6:26 AM

Gainers

AMPE

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s After-Market Session

By Benzinga Insights

September 1, 5:40 PM

Gainers SenesTech (NASDAQ:SNES) stock rose 28.0% to $0.64 during Thursday's after-market session. The market value of their outstanding shares is at $7.8 million.

ADIL